Certified by Founder Lodge
5AM Ventures
United States - San Francisco, California
INVESTOR
1 Disclosed Funding Rounds $100,000,000
7 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
5AM was founded in 2002 and pursues investments in advanced life science innovations, and seeks to be diversified across the biopharmaceutical therapeutics, and platform technologies. Within
| Company | Date | Round | Raised |
|---|---|---|---|
 CAMP4 Therapeutics |
July, 20 ,2022 | Series B | $100,000,000 |
 Ensoma |
February, 06 ,2023 | Series B | $85,000,000 |
 MapLight Therapeutics, Inc. |
October, 31 ,2023 | Series C | $225,000,000 |
 Radionetics Oncology |
January, 04 ,2024 | Series A | $52,500,000 |
 Latigo Biotherapeutics, Inc. |
February, 15 ,2024 | Series A | $135,000,000 |
 Karius |
May, 03 ,2024 | Series C | $100,000,000 |
 TMRW Life Sciences |
July, 25 ,2024 | Series D | $28,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
